S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 23 800 KRW 1.49% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Seegene Inc?
Write Note

Seegene Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Seegene Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Seegene Inc
KOSDAQ:096530
Net Income (Common)
â‚©29.5B
CAGR 3-Years
-63%
CAGR 5-Years
2%
CAGR 10-Years
14%
Celltrion Inc
KRX:068270
Net Income (Common)
â‚©187.1B
CAGR 3-Years
-30%
CAGR 5-Years
-5%
CAGR 10-Years
7%
SK Bioscience Co Ltd
KRX:302440
Net Income (Common)
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income (Common)
â‚©112B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income (Common)
â‚©88.8B
CAGR 3-Years
24%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Income (Common)
-â‚©2.9B
CAGR 3-Years
51%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Seegene Inc
Glance View

Market Cap
1.2T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
23 185.53 KRW
Overvaluation 3%
Intrinsic Value
Price
S

See Also

What is Seegene Inc's Net Income (Common)?
Net Income (Common)
29.5B KRW

Based on the financial report for Sep 30, 2024, Seegene Inc's Net Income (Common) amounts to 29.5B KRW.

What is Seegene Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
14%

The average annual Net Income (Common) growth rates for Seegene Inc have been -63% over the past three years , 2% over the past five years , and 14% over the past ten years .

Back to Top